New NIH Awards Will Help Those Who Just Missed The Cut

Healy unveils $30 million plan to provide interim funding for researchers struggling to secure NIH grants for their research WASHINGTON--In her first official appearance before Congress as National Institutes of Health director last month, Bernadine Healy delivered a gift to the scientific research community: a new $30 million awards program. Healy told the House appropriations subcommittee headed by Rep. William Natcher (D-Ky.) that by the end of September, NIH hopes to have thrown a lifelin

Written byJeffrey Mervis
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WASHINGTON--In her first official appearance before Congress as National Institutes of Health director last month, Bernadine Healy delivered a gift to the scientific research community: a new $30 million awards program.

Healy told the House appropriations subcommittee headed by Rep. William Natcher (D-Ky.) that by the end of September, NIH hopes to have thrown a lifeline to several hundred investigators who just missed having their ideas funded and need money to keep their labs afloat until the next round of awards.

The new program will be called the James Shannon director's awards, according to Healy, in honor of the legendary figure who headed NIH for 13 years during its period of tremendous growth from the late 1950s through the mid-1960s.

It will be funded in part from a $20 million discretionary fund that Congress created this year for the NIH director, supplemented by a "tax" of not more than 1 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies